Making trials matter: pragmatic and explanatory trials and the problem of applicability
Open Access
- 3 June 2009
- journal article
- review article
- Published by Springer Nature in Trials
- Vol. 10 (1) , 37
Abstract
Randomised controlled trials are the best research design for decisions about the effect of different interventions but randomisation does not, of itself, promote the applicability of a trial's results to situations other than the precise one in which the trial was done. While methodologists and trialists have rightly paid great attention to internal validity, much less has been given to applicability.Keywords
This publication has 58 references indexed in Scilit:
- Implementing, Embedding, and Integrating Practices: An Outline of Normalization Process TheorySociology, 2009
- Improving the reporting of pragmatic trials: an extension of the CONSORT statementBMJ, 2008
- The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaborationQuality and Safety in Health Care, 2008
- What is missing from descriptions of treatment in trials and reviews?BMJ, 2008
- Generalizing from clinical trial data: A case study. The risk of suicidality among pediatric antidepressant usersStatistics in Medicine, 2008
- Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort studyBMJ, 2007
- Parenting intervention in Sure Start services for children at risk of developing conduct disorder: pragmatic randomised controlled trialBMJ, 2007
- External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax, 2007
- Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trialBMJ, 2007
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005